Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Shanxi CY Pharma Buys Controlling Interest in Baoling Group

publication date: Jun 21, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shanxi CY Pharmaceutical Co. will purchase a stake of at least 80% in Hangzhou Baoling Group Co., Ltd. Baoling Group owns 75% of Zhejiang Baoling Pharmaceutical Co., Ltd., which produces healthcare and drug products for pregnant women. The purchase price was not disclosed. More details....

Stock Symbol: (SHE: 300254)

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors